Next Article in Journal
Contemporary Management of Stage I Testicular Seminoma: A Survey of Canadian Radiation Oncologists
Previous Article in Journal
The 3rd Annual Ontario Thoracic Cancer Conference at Niagara-on-the-Lake
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Trastuzumab: A Cardiologist’s Perspective

Ctr. Malad Sein Deschenes Fabia, University Laval, CHAUQ, Quebec City, PQ, Canada
Curr. Oncol. 2008, 15(3), 162-163; https://doi.org/10.3747/co.v15i3.300
Submission received: 4 March 2008 / Revised: 5 April 2008 / Accepted: 6 May 2008 / Published: 1 June 2008

Abstract

A review of the randomized clinical trials of adjuvant trastuzumab in human epidermal growth factor receptor (HER2)—positive breast cancer demonstrates the great benefit of this monoclonal antibody whose potential cardiotoxicity is a fascinating problem for the cardiologist 1. [...]

Share and Cite

MDPI and ACS Style

Côté, M.A. Trastuzumab: A Cardiologist’s Perspective. Curr. Oncol. 2008, 15, 162-163. https://doi.org/10.3747/co.v15i3.300

AMA Style

Côté MA. Trastuzumab: A Cardiologist’s Perspective. Current Oncology. 2008; 15(3):162-163. https://doi.org/10.3747/co.v15i3.300

Chicago/Turabian Style

Côté, Marc André. 2008. "Trastuzumab: A Cardiologist’s Perspective" Current Oncology 15, no. 3: 162-163. https://doi.org/10.3747/co.v15i3.300

Article Metrics

Back to TopTop